Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.
Location: United States
Total raised: $115M
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 04.03.2026 | Series C | $50M | - |
| 25.06.2020 | - | $40M | - |
| 17.07.2018 | - | $25M | - |
Mentions in press and media 15
| Date | Title | Description |
| 09.03.2026 | Polares Medical Secures $50M for MRace System U.S. Expansion | Polares Medical secured $50 million in Series C funding. This capital fuels extensive U.S. expansion for its MRace system. MRace presents a novel transcatheter solution for mitral regurgitation. It expands treatment options for complex hear... |
| 04.03.2026 | USD 50 million to advance Polares Medical U.S. expansion | Polares is focused on the large and growing population of patients suffering from mitral regurgitation, a heart valve disease, particularly those with secondary MR, a condition commonly treated with transcatheter edge-to-edge repair (TEER)... |
| 03.03.2026 | Polares Medical Raises $50 Million Series C to Advance U.S. Expansion of MRace Following Strong Clinical Results | Polares Medical SA (“Polares”), a clinical-stage structural heart company developing the MRace Posterior Leaflet Replacement (PLR) system for mitral regurgitation (MR), today announced the closing of a $50 million Series C financing. The ov... |
| 03.03.2026 | Polares Medical: $50 Million Series C Raised To Advance U.S. Expansion Of Structural Heart Device | Polares Medical SA, a clinical-stage structural heart company developing a transcatheter therapy for mitral regurgitation, has raised $50 million in a Series C financing to support the U.S. expansion of its MRace Posterior Leaflet Replaceme... |
| 23.09.2020 | Healthcare VC Firm Longitude Capital Closes $585M Fund | What You Should Know: – Healthcare venture capital firm Longitude Capital announces the close of its $585M Longitude Venture Partners IV, L.P. (“LVP4”) fund to invest in transformative healthcare companies. – LVP4 will invest opportunistica... |
| 23.09.2020 | Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies | - Longitude Venture Partners IV will build on the Firm’s commitment to improve clinical outcomes, enhance patient quality of life, and drive efficiency in healthcare delivery - - In 2020 to date, Longitude portfolio companies announced 4 IP... |
| 25.06.2020 | Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies | |
| 25.06.2020 | Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies | Polares Medical SA, a clinical stage medical technology company based in Lausanne announced today the closing of a $40 million financing led by Longitude Capital (Menlo Park) with the participation of Decheng Capital (Menlo Park / Shanghai)... |
| 25.06.2020 | Polares Medical Closes $40M Financing | Polares Medical SA, a Lausanne, Switzerland-based clinical stage medical technology company, closed a $40m financing. The round was led by Longitude Capital with the participation from Decheng Capital, Endeavour Vision, IDO Investments, Ear... |
| 18.07.2018 | Polares Medical closes a $25M financing round |
Show more